Resistant hypertension indicates that the blood pressure cannot reach the target value despite standard drug treatment, which harbors an increased risk for cardiovascular diseases. The role of the carotid sinus in regulating blood pressure has long been observed; thereby, the idea that treating resistant hypertension by stimulating carotid baroreceptors emerged. Nevertheless, this idea has been abandoned for years due to technical limitations. Recently, with the evolutions in implantable electrical devices, expectations for treating resistant hypertension with baroreceptor stimulation have increased. Positive results from several multicenter clinical trials further captured the researchers' enthusiasm for more effective baroreceptor-stimulating devices. This study reviews the recent progress in baroreceptor stimulation as a treatment alternative for resistant hypertension.

Keywords:
Carotid sinus, Baroreceptor, Electrical stimulation, Resistant hypertension
1.
Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al: Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125:1635-1642.
2.
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al: Resistant hypertension: diagnosis, evaluation, and treatment a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403-1419.
3.
Acelajado MC, Calhoun DA: Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment. Cardiol Clin 2010;28:639-654.
4.
Thrasher TN: Unloading arterial baroreceptors causes neurogenic hypertension. Am J Physiol Regul Integr Comp Physiol 2002;282:R1044-R1053.
5.
Papademetriou V, Doumas M, Faselis C, Tsioufis C, Douma S, Gkaliagkousi E, et al: Carotid baroreceptor stimulation for the treatment of resistant hypertension. Int J Hypertens 2011;2011:964394.
6.
Warner HR: The frequency-dependent nature of blood pressure regulation by the carotid sinus studied with an electric analog. Circ Res 1958;6:35-40.
7.
Cooper A: Guy's hospital report; in Heymans C, Neil E (eds): Reflexogenic Areas of the Cardiovascular System. London, J&A Churchill, 1858, p 457.
8.
Bilgutay AM, Lillehei CW: Treatment of hypertension with an implantable electronic device. JAMA 1965;191:649-653.
9.
Bilgutay AM, Lillehei CW: Surgical treatment of hypertension with reference to baropacing. Am J Cardiol 1966;17:663-667.
10.
McCubbin J, Green J, Page IH: Baroceptor function in chronic renal hypertension. Circ Res 1956;4:205-210.
11.
Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS: Diminished baroreflex sensitivity in high blood pressure. Circulation 1969;39:48-54.
12.
Thrasher TN: Baroreceptors and the long‐term control of blood pressure. Exp Physiol 2004;89:331-335.
13.
Kougias P, Weakley SM, Yao Q, Lin PH, Chen C: Arterial baroreceptors in the management of systemic hypertension. Med Sci Monit 2010;16:RA1.
14.
Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS: Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 2004;43:306-311.
15.
Barrett AM, Irwin ED: Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension? Curr Hypertens Rep 2005;7:193-198.
16.
Lohmeier TE, Dwyer TM, Hildebrandt DA, Irwin ED, Rossing MA, Serdar DJ, et al: Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension 2005;46:1194-1200.
17.
Mohaupt M, Cain C, Frey F: Chronic electrical activation of the carotid sinus baroreflex by implanted electrodes for blood pressure reduction in man: first experience in a hypertensive patient. Kidney Blood Press Res 2004;27:299.
18.
Tordoir J, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, et al: An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007;33:414-421.
19.
Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, et al: Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010;55:619-626.
20.
Illig KA, Levy M, Sanchez L, Trachiotis GD, Shanley C, Irwin E, et al: An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg 2006;44:1213-1218.
21.
Scheffers IJ, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, et al: Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 2010;56:1254-1258.
22.
Alnima T, Scheffers I, De Leeuw PW, Winkens B, Jongen-Vancraybex H, Tordoir JH, et al: Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens 2012;30:1665-1670.
23.
Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al: Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 2011;58:765-773.
24.
Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD: Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 2012;6:152-158.
25.
Hoppe UC, Brandt M-C, Wachter R, Beige J, Rump LC, Kroon AA, et al: Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens 2012;6:270-276.
26.
Udo EO, Zuithoff N, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, et al: Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 2012;9:728-735.
27.
Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, et al: Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 2009;54:530-536.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.